rs879254845

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PP1_ModeratePM2PP4PS4_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1244A>G (p.Asp415Gly) variant is classified as Likely Pathogenic, for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PS4_Moderate, PP1_Moderate and PP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 June 2023.The supporting evidence is as follows: PM2: This variant is absent from gnomAD (gnomAD v2.1.1).PS4_Supporting, PP4: Variant meets PM2 and is identified in 2 unrelated cases who fulfill criteria for FH (at least 1 case from PMID 11810272 (Fouchier et al., 2001), The Netherlands; 1 case from PMID 10978268 (Bertolini et al., 2000), Italy).PP1_Moderate: Variant segregates with FH phenotype in at least 5 informative meiosis (minimum 4) from 1 family in PMID 10978268 (Bertolini et al., 2000), Italy. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10585372/MONDO:0007750/013

Frequency

Genomes: not found (cov: 29)

Consequence

LDLR
NM_000527.5 missense

Scores

7
5
6

Clinical Significance

Likely pathogenic reviewed by expert panel P:2B:1

Conservation

PhyloP100: 3.08

Publications

4 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
MIR6886 (HGNC:50121): (microRNA 6886) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PS4
For more information check the summary or visit ClinGen Evidence Repository.
PM2
For more information check the summary or visit ClinGen Evidence Repository.
PP1
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.1244A>Gp.Asp415Gly
missense
Exon 9 of 18NP_000518.1
LDLR
NM_001195798.2
c.1244A>Gp.Asp415Gly
missense
Exon 9 of 18NP_001182727.1
LDLR
NM_001195799.2
c.1121A>Gp.Asp374Gly
missense
Exon 8 of 17NP_001182728.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.1244A>Gp.Asp415Gly
missense
Exon 9 of 18ENSP00000454071.1
LDLR
ENST00000252444.10
TSL:1
c.1502A>Gp.Asp501Gly
missense
Exon 9 of 18ENSP00000252444.6
LDLR
ENST00000558013.5
TSL:1
c.1244A>Gp.Asp415Gly
missense
Exon 9 of 18ENSP00000453346.1

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
29
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions as Germline
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
-
1
Hypercholesterolemia, familial, 1 (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.26
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Pathogenic
0.84
D
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.11
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.93
D
M_CAP
Pathogenic
0.67
D
MetaRNN
Pathogenic
0.86
D
MetaSVM
Uncertain
0.32
D
MutationAssessor
Benign
0.98
L
PhyloP100
3.1
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-4.2
D
REVEL
Pathogenic
0.74
Sift
Benign
0.062
T
Sift4G
Benign
0.32
T
Polyphen
0.0020
B
Vest4
0.38
MutPred
0.85
Loss of solvent accessibility (P = 0.0364)
MVP
1.0
MPC
0.37
ClinPred
0.84
D
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.48
gMVP
0.98
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs879254845; hg19: chr19-11224011; API